Surrozen logo

Surrozen

SRZN | NASDAQ
Chart Builder DCF Calculator
$32.32
+$0.71 (+2.25%)
At close: Nov 16, 2026, 4:00 PM ET
$32.32
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
+2.25%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #690/1021 (Top 68%)

Key Statistics

Market Data

Market Cap $380.54M
1D Range
30.86 33.09
52W Range
12.80 34.13

Valuation (TTM)

PE -0.69
PB -1.13
EV/EBITDA -0.73

Valuation (NTM)

Forward PE N/A
Forward PEG -0.01
Price Target $67.00
Loading financial charts...

Profile

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics t...

Sector Healthcare
Industry Biotechnology
Employees 44
IPO Date Jan 11, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 9, 2026
EPS
-$11.02
Miss -901.82%
REV
-$9.87M
Miss -2177.89%
Next Earnings
Mar 22, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$67.00
Upside
+107.30%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.